| |
|
Drug Related Products News
|
Labopharm to present at Dundee Emerging Growth Summit
Fri 7:00 am ET (PR Newswire)
Labopharm Inc. today announced that James R. Howard-Tripp, President & Chief Executive Officer of the Company, will present at the Dundee Emerging Growth Summit at the Design Exchange in Toronto, on Thursday, November 26, 2009 at 2:30 p.m.
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 14B | | Price
/ Earnings: | 52.1 | | Price
/ Book: | 8.9 | | Net
Profit Margin (mrq): | 3.0% | | Price
To Free Cash Flow (mrq): | 79.3 | | Return
on Equity: | 6.8% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 1.4% |
|